Surgery may extend life for men with early bone metastases in prostate cancer
NCT ID NCT02454543
First seen Jan 12, 2026 · Last updated May 14, 2026 · Updated 20 times
Summary
This study looks at whether removing the prostate and nearby lymph nodes, along with standard treatments, helps men with prostate cancer that has spread to a few bones live longer and delay the cancer becoming resistant to hormone therapy. About 452 men with intermediate- or high-risk prostate cancer and limited bone metastases are being followed for up to 10 years. The goal is to see if surgery improves survival, slows progression, and maintains quality of life compared to standard therapy alone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Markus Graefen
Hamburg, Nein, 20246, Germany
Conditions
Explore the condition pages connected to this study.